Market Place
Sourcing Support
All News #Library
FDA Issues Form 483 to Zydus Lidescience
30 Oct 2025 //
FDA
Enforcement Report - Week of April 16, 2025
16 Apr 2025 //
FDA
Enforcement Report - Week of March 12, 2025
12 Mar 2025 //
FDA
Zydus Lifesciences Receives FDA Warning Letter
09 Oct 2024 //
FDA
Zydus Lifesciences Receives FDA Warning Letter
10 Sep 2024 //
FDA
FDA Issues form 483 to Zydus Life sciences
30 Apr 2024 //
FDA
FDA Issues Form 483 to Zydus Lifesciences
12 Apr 2024 //
FDA
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Enforcement Report - Week of October 11, 2023
11 Oct 2023 //
FDA
Enforcement Report - Week of March 22, 2023
22 Mar 2023 //
FDA
FDA Issues Form 483 to Cadila Healthcare Limited
19 Mar 2022 //
FDA
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Cadila Healthcare Receives FDA Warning Letter
13 Nov 2019 //
FDA
Enforcement Report - Week of July 17, 2019
17 Jul 2019 //
FDA
Enforcement Report - Week of May 15, 2019
15 May 2019 //
FDA
FDA Issues Form 483 to Cadila Healthcare
06 May 2019 //
FDA
Enforcement Report - Week of December 6, 2017
06 Dec 2017 //
FDA
US FDA Issues Form 483 to Cadila Healthcare Limited
15 Apr 2017 //
FDA
Cadila Healthcare Limited receives warning letter due to cGMP deviations
31 Dec 2015 //
FDA
Most Pharma Cos Earn USFDA Wrath Over Data Integrity Issues
29 Dec 2014 //
THE TIMES OF INDIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.